{"id":"https://openalex.org/W2062988834","doi":"https://doi.org/10.2174/138161211797440212","title":"Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected","display_name":"Do ATP-Binding Cassette Transporters Cause Pharmacoresistance in Epilepsy? Problems and Approaches in Determining which Antiepileptic Drugs are Affected","publication_year":2011,"publication_date":"2011-09-01","ids":{"openalex":"https://openalex.org/W2062988834","doi":"https://doi.org/10.2174/138161211797440212","mag":"2062988834","pmid":"https://pubmed.ncbi.nlm.nih.gov/21827408"},"language":"en","primary_location":{"id":"doi:10.2174/138161211797440212","doi":"https://doi.org/10.2174/138161211797440212","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161211797440212","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010235451","display_name":"Wolfgang L\u00f6scher","orcid":"https://orcid.org/0000-0002-9648-8973","observed_orcids":["https://orcid.org/0000-0002-9648-8973"]},"institutions":[{"id":"https://openalex.org/I189991","display_name":"University of Veterinary Medicine Hannover, Foundation","ror":"https://ror.org/015qjqf64","country_code":"DE","type":"education","lineage":["https://openalex.org/I189991"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Loscher","raw_affiliation_strings":["Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary, Medicine, Hannover, Germany. wolfgang.loescher@tiho-hannover.de","Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary, Medicine, Hannover, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary, Medicine, Hannover, Germany. wolfgang.loescher@tiho-hannover.de","institution_ids":["https://openalex.org/I189991"]},{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary, Medicine, Hannover, Germany","institution_ids":["https://openalex.org/I189991"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017312953","display_name":"Carlos Luna\u2010Tort\u00f3s","orcid":"https://orcid.org/0000-0003-3329-5610","observed_orcids":["https://orcid.org/0000-0003-3329-5610"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Carlos Luna-Tortos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078347332","display_name":"Kerstin R\u00f6mermann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kerstin Romermann","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000548591","display_name":"Maren Fedrowitz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189991","display_name":"University of Veterinary Medicine Hannover, Foundation","ror":"https://ror.org/015qjqf64","country_code":"DE","type":"education","lineage":["https://openalex.org/I189991"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Maren Fedrowitz","raw_affiliation_strings":["Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine, Bunteweg 17, D-30559 Hannover, Germany.,Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Toxicology and Pharmacy, University of Veterinary Medicine, Bunteweg 17, D-30559 Hannover, Germany.,Germany","institution_ids":["https://openalex.org/I189991"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.0628,"has_fulltext":false,"cited_by_count":151,"citation_normalized_percentile":{"value":0.97346497,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"17","issue":"26","first_page":"2808","last_page":"2828"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.005799999926239252,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/abc-transporters","display_name":"ABC transporters","score":0.8479999899864197},{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.8730000257492065},{"id":"https://openalex.org/keywords/multidrug-resistance-1","display_name":"multidrug resistance 1","score":0.781000018119812},{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.7519999742507935},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.6449999809265137},{"id":"https://openalex.org/keywords/epilepsy","display_name":"epilepsy","score":0.800000011920929},{"id":"https://openalex.org/keywords/blood-brain-barrier","display_name":"blood-brain barrier","score":0.9660000205039978},{"id":"https://openalex.org/keywords/drug-efflux","display_name":"drug efflux","score":0.8650000095367432},{"id":"https://openalex.org/keywords/drug-penetration","display_name":"drug penetration","score":0.6499999761581421},{"id":"https://openalex.org/keywords/cytochrome-p450","display_name":"cytochrome P450","score":0.8029999732971191}],"concepts":[{"id":"https://openalex.org/C200082930","wikidata":"https://www.wikidata.org/wiki/Q22327148","display_name":"Efflux","level":2,"score":0.8439986705780029},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.7789481282234192},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6957306265830994},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.5968506336212158},{"id":"https://openalex.org/C44312359","wikidata":"https://www.wikidata.org/wiki/Q286958","display_name":"ATP-binding cassette transporter","level":4,"score":0.5646283626556396},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.4943807125091553},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.49336686730384827},{"id":"https://openalex.org/C149011108","wikidata":"https://www.wikidata.org/wiki/Q652985","display_name":"Transporter","level":3,"score":0.4863656163215637},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.46596696972846985},{"id":"https://openalex.org/C2777670902","wikidata":"https://www.wikidata.org/wiki/Q492038","display_name":"Human brain","level":2,"score":0.46406230330467224},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.4611179828643799},{"id":"https://openalex.org/C60903277","wikidata":"https://www.wikidata.org/wiki/Q2051926","display_name":"Paracellular transport","level":4,"score":0.4301382303237915},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.34060513973236084},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.33773618936538696},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.18938854336738586},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1804436445236206},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.16346174478530884},{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.16183456778526306},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.15943968296051025},{"id":"https://openalex.org/C120882062","wikidata":"https://www.wikidata.org/wiki/Q28352","display_name":"Permeability (electromagnetism)","level":3,"score":0.13809508085250854},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.07829999923706055},{"id":"https://openalex.org/C41625074","wikidata":"https://www.wikidata.org/wiki/Q176088","display_name":"Membrane","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D001692","descriptor_name":"Biological Transport","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001812","descriptor_name":"Blood-Brain Barrier","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003577","descriptor_name":"Cytochrome P-450 Enzyme System","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004351","descriptor_name":"Drug Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004827","descriptor_name":"Epilepsy","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018528","descriptor_name":"ATP-Binding Cassette Transporters","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/138161211797440212","doi":"https://doi.org/10.2174/138161211797440212","is_oa":false,"landing_page_url":"https://doi.org/10.2174/138161211797440212","pdf_url":null,"source":{"id":"https://openalex.org/S55674637","display_name":"Current Pharmaceutical Design","issn_l":"1381-6128","issn":["1381-6128","1873-4286"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Pharmaceutical Design","raw_type":"journal-article"},{"id":"pmid:21827408","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21827408","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current pharmaceutical design","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1993337516","https://openalex.org/W2037608619","https://openalex.org/W1967913742","https://openalex.org/W2021383535","https://openalex.org/W2513833733","https://openalex.org/W1985906464","https://openalex.org/W2917723648","https://openalex.org/W1870592","https://openalex.org/W2149016411","https://openalex.org/W1977595701"],"abstract_inverted_index":{"Resistance":[0],"to":[1,21,125,136,149,286,312],"multiple":[2],"antiepileptic":[3],"drugs":[4],"(AEDs)":[5],"is":[6,103,123,161,187],"a":[7,42,130,163,189,223],"common":[8],"problem":[9],"in":[10,69,82,133,138,178,208,209,257,292,316,328],"epilepsy,":[11],"affecting":[12],"at":[13,150],"least":[14,151],"30%":[15],"of":[16,32,44,55,73,85,109,115,141,165,184,191,212,235,297,306],"patients.":[17],"One":[18],"prominent":[19],"hypothesis":[20],"explain":[22],"this":[23,146],"resistance":[24,135],"suggests":[25],"an":[26],"inadequate":[27],"penetration":[28],"or":[29,277],"excess":[30],"efflux":[31,46,219,288],"AEDs":[33,137,181,195,247,327],"across":[34],"the":[35,52,56,192,213,233,266,279,287,303,313],"blood":[36],"-":[37,143],"brain":[38,71,107,304],"barrier":[39],"(BBB)":[40],"as":[41,49,205,216],"result":[43],"overexpressed":[45],"transporters":[47],"such":[48,215],"P-glycoprotein":[50],"(Pgp),":[51],"encoded":[53],"product":[54],"multidrug":[57],"resistance-":[58],"1":[59],"(MDR1,":[60],"ABCB1)":[61],"gene.":[62],"Pgp":[63,95,101,116,128,186,206],"and":[64,79,269,295],"MDR1":[65],"are":[66,171,182,196,201,248,282,331],"markedly":[67],"increased":[68,100],"epileptogenic":[70],"tissue":[72],"patients":[74,330],"with":[75,105,325],"AED-resistant":[76,91],"partial":[77,86],"epilepsy":[78,142,155],"following":[80],"seizures":[81],"rodent":[83,89,139],"models":[84,140,211],"epilepsy.":[87],"In":[88,284],"models,":[90],"rats":[92],"exhibit":[93],"higher":[94],"levels":[96,108],"than":[97],"responsive":[98],"animals;":[99],"expression":[102],"associated":[104],"lower":[106],"AEDs;":[110],"and,":[111],"most":[112],"importantly,":[113],"co-administration":[114],"inhibitors":[117],"reverses":[118],"AED":[119,267],"resistance.":[120],"Thus,":[121],"it":[122,160,254],"reasonable":[124],"conclude":[126],"that":[127,194,244,260],"plays":[129],"significant":[131],"role":[132],"mediating":[134],"however,":[144],"whether":[145],"phenomenon":[147],"extends":[148],"some":[152],"human":[153,174,185,251],"refractory":[154],"remains":[156],"unclear,":[157],"particularly":[158],"because":[159],"still":[162],"matter":[164],"debate":[166],"which":[167,180,200,231],"AEDs,":[168],"if":[169,274],"any,":[170],"transported":[172,249],"by":[173,250],"Pgp.":[175,252],"The":[176],"difficulty":[177],"determining":[179],"substrates":[183,207],"mainly":[188],"consequence":[190],"fact":[193],"highly":[197,263],"permeable":[198],"compounds,":[199],"not":[202,271],"easily":[203],"identified":[204,273],"vitro":[210],"BBB,":[214],"monolayer":[217],"(Transwell(\u00ae))":[218],"assays.":[220],"By":[221],"using":[222,320],"modified":[224],"assay":[225],"(concentration":[226],"equilibrium":[227],"transport":[228,262],"assay;":[229],"CETA),":[230],"minimizes":[232],"influence":[234],"high":[236],"transcellular":[237],"permeability,":[238],"two":[239],"groups":[240],"have":[241],"recently":[242],"demonstrated":[243,256],"several":[245],"major":[246],"Importantly,":[253],"was":[255],"these":[258,310],"studies":[259,319],"Pgp-mediated":[261],"depends":[264],"on":[265],"concentration":[268],"may":[270],"be":[272],"concentrations":[275],"below":[276],"above":[278],"therapeutic":[280],"range":[281],"used.":[283],"addition":[285],"transporters,":[289],"seizure-induced":[290],"alterations":[291],"BBB":[293],"integrity":[294],"activity":[296],"drug":[298],"metabolizing":[299],"enzymes":[300],"(CYPs)":[301],"affect":[302],"uptake":[305],"AEDs.":[307],"For":[308],"translating":[309],"findings":[311],"clinical":[314],"arena,":[315],"vivo":[317],"imaging":[318],"positron":[321],"emission":[322],"tomography":[323],"(PET)":[324],"(11)C-labelled":[326],"epileptic":[329],"under":[332],"way.":[333]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":38},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":13},{"year":2016,"cited_by_count":12},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":12},{"year":2013,"cited_by_count":14},{"year":2012,"cited_by_count":9}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}